Objective. This article reviews the epidemiology of chronic type C hepatitis and the
neuropsychiatric complications of its treatment with Interferon á and Ribavirin. Review …

The article presents the results of a clinico-psychopathological study of depressive disorder
(DD) in 91 patients with chronic C hepatitis and no psychiatric background during combined …

About 170 million individuals can be found with chronic hepatitis C viral infection all over the
world. The occurence of depression is more frequent among the persons than in the healthy …

Approximately 170 million people worldwide suffer from chronic hepatitis C. Depression is
more prevalent among people with chronic viral hepatitis C as compared to the normal …

Background Interferon alpha, used in hepatitis C virus (HCV) infection causes many
neuropsychiatric side effects: emotional disturbances, chronic fatigue, cognitive impairment …

Background: Several studies found a high incidence rate of neuro-psychiatric complications
during long-term therapy with interferon alpha (IFNα), eg slowness, severe fatigue …

Background: Interferon-Alfa (IFN-α) has been the mainstay of treatment for chronic hepatitis
C. It has the potential to alter the course of chronic hepatitis C and prevent complications …

Chronic infection with the hepatitis C virus is a common and growing problem, often affecting
persons with psychiatric and substance use problems. Neuropsychiatric symptoms are …

Background: The current standard treatment of chronic hepatitis C in Bosnia and
Herzegovina consists of pegylated interferon alpha in combination with ribavirin. Interferon …

Chronic hepatitis is often associated with neuropsychiatric disorders. Interferon (IFN) is the
drug most widely used to treat this disease, and its side effects, such as depression, often …